Evaluation of resveratrol and piceatannol cytotoxicity in macrophages, T cells, and skin cells

Arhiv za Higijenu Rada i Toksikologiju

Volumn 58, Issue 3, 2007, Pages 293-304

  Radkar, Vijayalaxmi ^a   Hardej, Diane ^a   Lau Cam, Cesar ^a   Billack, Blase ^a  

^a ST JOHN'S UNIVERSITY   (United States)

Author keywords

A 431 cells; CEM T cells; Glutathione; RAW264.7 cells; TBARS; Viability; Zymosan

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; FORMAZAN; GLUTATHIONE; PICEATANNOL; RESVERATROL; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CARCINOMA CELL; CELL ACTIVATION; CELL CULTURE; CELL PROLIFERATION; CELL STIMULATION; CELL TRANSFORMATION; CELL TYPE; CELL VIABILITY; CHEMICAL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; LC 50; MACROPHAGE; MOUSE; NONHUMAN; SKIN CELL; SQUAMOUS CELL CARCINOMA; T LYMPHOCYTE; TUMOR CELL;

ANIMALS; ANTIOXIDANTS; CELL PROLIFERATION; CELL SURVIVAL; GLUTATHIONE; HUMANS; LIPID PEROXIDATION; MACROPHAGES; MICE; SKIN; STILBENES; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 35148901170     PISSN: 00041254     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10004-007-0020-8     Document Type: Article

References (65)

1. Delmas D, Lancon A, Colin D, Jannin B, Latruffe N. Resveratrol as a chemopreventive agent: a promising molecule for fighting cancer. Curr Drug Targets 2006;7:423-42.
2. Ibern-Gomez M, Roig-Perez S, Lamuela-Raventos RM, Torre-Boronat MC. Resveratrol and piceid levels in natural and blended peanut butters. J Agric Food Chem 2000;48:6352-4.
3. Burns J, Yokota T, Ashihara H, Lean ME, Crozier A. Plant foods and herbal sources of resveratrol. J Agric Food Chem 2002;50:3337-40.
4. Sobolev VS, Cole RJ. Trans-resveratrol content in commercial peanuts and peanut products. J Agric Food Chem 1999;47:1435-9.
5. Soleas GJ, Diamandis EP, Goldberg DM. Resveratrol: a molecule whose time has come? And gone? Clin Biochem 1997;30:91-113.
6. Basly JP, Marre-Fournier F, Le Bail JC, Habrioux G, Chulia AJ. Estrogenic/antiestrogenic and scavenging properties of (E)- and (Z)-resveratrol. Life Sci 2000;66:769-77.
7. Gehm BD, McAndrews JM, Chien PY, Jameson JL. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc Natl Acad Sci USA 1997;94:14138-43.
8. el Mowafy AM, Abou-Zeid LA, Edafiogho I. Recognition of resveratrol by the human estrogen receptor-alpha: a molecular modeling approach to understand its biological actions. Med Princ Pract 2002;11:86-92.
9. Jeandet P, Douillet-Breuil AC, Bessis R, Debord S , Sbaghi M, Adrian M. Phytoalexins from the Vitaceae: biosynthesis, phytoalexin gene expression in transgenic plants, antifungal activity, and metabolism. J Agric Food Chem 2002;50:2731-41.
10. Watts KT, Lee PC, Schmidt-Dannert C. Biosynthesis of plant-specific stilbene polyketides in metabolically engineered Escherichia coli. BMC Biotechnol 2006;6:22.
11. Pervaiz S. Resveratrol: from grapevines to mammalian biology. FASEB J 2003;17:1975-85.
12. Ulrich S, Wolter F, Stein JM. Molecular mechanisms of the chemopreventive effects of resveratrol and its analogs in carcinogenesis. Mol Nutr Food Res 2005;49:452-61.
13. Bhat KPL, Kosmeder JW, Pezzuto JM. Biological effects of resveratrol. Antioxid Redox Signal 2001;3:1041-64.
14. Kris-Etherton PM, Hecker KD, Bonanome A, Coval SM, Binkoski AE, Hilpert KF, Griel AE, Etherton TD. Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer. Am J Med 2002;113(Suppl 9B):71S-88S.
15. Crowell JA, Korytko PJ, Morrissey RL, Booth TD, Levine BS. Resveratrol-associated renal toxicity. Toxicol Sci 2004;82:614-9.
16. de la Lastra CA, Villegas I. Resveratrol as an antiinflammatory and anti-aging agent: mechanisms and clinical implications. Mol Nutr Food Res 2005;49:405-30.
17. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezzuto JM. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997;275:218-20.
18. Falchetti R, Fuggetta MP, Lanzilli G, Tricarico M, Ravagnan G. Effects of resveratrol on human immune cell function. Life Sci 2001;70:81-96.
19. Ragione FD, Cucciolla V, Borriello A, Pietra VD, Racioppi L, Soldati G, Manna C, Galletti P, Zappia V. Resveratrol arrests the cell division cycle at S/G2 phase transition. Biochem Biophys Res Commun 1998;250:53-8.
20. Bernhard D, Tinhofer I, Tonko M, Hubl H, Ausserlechner MJ, Greil R, Kofler R, Csordas A. Resveratrol causes arrest in the S-phase prior to Fas-independent apoptosis in CEM-C7H2 acute leukemia cells. Cell Death Differ 2000;7:834-42.
21. Tsan MF, White JE, Maheshwari JG, Chikkappa G. Anti-leukemia effect of resveratrol. Leuk Lymphoma 2002;43:983-7.
22. Zunino SJ, Storms DH. Resveratrol-induced apoptosis is enhanced in acute lymphoblastic leukemia cells by modulation of the mitochondrial permeability transition pore. Cancer Lett 2006;240:123-34.
23. Wu SL, Yu L, Pan CE, Jiao XY, Lv Y, Fu J, Meng KW. Apoptosis of lymphocytes in allograft in a rat liver transplantation model induced by resveratrol. Pharmacol Res 2006;54:19-23.
24. Jang DS, Kang BS, Ryu SY, Chang IM, Min KR, Kim Y. Inhibitory effects of resveratrol analogs on unopsonized zymosan-induced oxygen radical production. Biochem Pharmacol 1999;57:705-12.
25. Djoko B, Chiou RY, Shee JJ, Liu YW. Characterization of immunological activities of peanut stilbenoids, arachidin-1, piceatannol, and resveratrol on lipopolysaccharide-induced inflammation of RAW 264.7 macrophages. J Agric Food Chem 2007;55:2376-83.
26. Kim AL, Zhu Y, Zhu H, Han L, Kopelovich L, Bickers DR, Athar M. Resveratrol inhibits proliferation of human epidermoid carcinoma A431 cells by modulating MEK1 and AP-1 signalling pathways. Exp Dermatol 2006;15:538-46.
27. Ahmad N, Adhami VM, Afaq F, Feyes DK, Mukhtar H. Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells. Clin Cancer Res 2001;7:1466-73.
28. Adhami VM, Afaq F, Ahmad N. Involvement of the retinoblastoma (pRb)-E2F/DP pathway during antiproliferative effects of resveratrol in human epidermoid carcinoma (A431) cells. Biochem Biophys Res Commun 2001;288:579-85.
29. Niles RM, Cook CP, Meadows GG, Fu YM, McLaughlin JL, Rankin GO. Resveratrol is rapidly metabolized in athymic (nu/nu) mice and does not inhibit human melanoma xenograft tumor growth. J Nutr 2006;136:2542-6.
30. Raschke WC, Baird S, Ralph P, Nakoinz I. Functional macrophage cell lines transformed by Abelson leukemia virus. Cell 1978;15:261-7.
31. Giard DJ, Aaronson SA, Todaro GJ, Arnstein P, Kersey JH, Dosik H, Parks WP. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst 1973;51:1417-23.
32. Foley GE, Lazarus H, Farber S, Uzman BG, Boone BA, McCarthy RE. Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia. Cancer 1965;18:522-9.
33. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63.
34. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem 1969;27:502-22.
35. Fraga CG, Leibovitz BE, Tappel AL. Lipid peroxidation measured as thiobarbituric acid-reactive substances in tissue slices: characterization and comparison with homogenates and microsomes. Free Radic Biol Med 1988;4:155-61.
36. Stervbo U, Vang O, Bonnesen C. Time- and concentration-dependent effects of resveratrol in HL-60 and HepG2 cells. Cell Prolif 2006;39:479-93.
37. Surh YJ, Hurh YJ, Kang JY, Lee E, Kong G, Lee SJ. Resveratrol, an antioxidant present in red wine, induces apoptosis in human promyelocytic leukemia (HL-60) cells. Cancer Lett 1999;140:1-10.
38. Tsan MF, White JE, Maheshwari JG, Bremner TA, Sacco J. Resveratrol induces Fas signalling-independent apoptosis in THP-1 human monocytic leukaemia cells. Br J Haematol 2000;109:405-12.
39. Velculescu VE, El Deiry WS. Biological and clinical importance of the p53 tumor suppressor gene. Clin Chem 1996;42(6 Pt 1):858-68.
40. Dong Z. Effects of food factors on signal transduction pathways. Biofactors 2000;12:17-28.
41. Cimoli G, Malacarne D, Ponassi R, Valenti M, Alberti S, Parodi S. Meta-analysis of the role of p53 status in isogenic systems tested for sensitivity to cytotoxic antineoplastic drugs. Biochim Biophys Acta 2004;1705:103-20.
42. Park DJ, Nakamura H, Chumakov AM, Said JW, Miller CW, Chen DL, Koeffler KP. Transactivational and DNA binding abilities of endogenous p53 in p53 mutant cell lines. Oncogene 1994;9:1899-906.
43. Wong RP, Tsang WP, Chau PY, Co NN, Tsang TY, Kwok TT. p53-R273H gains new function in induction of drug resistance through down-regulation of procaspase-3. Mol Cancer Ther 2007;6:1054-61.
44. Schneider Y, Chabert P, Stutzmann J, Coelho D, Fougerousse A, Gosse F, Launary JF, Brouillard R, Raul F. Resveratrol analog (Z)-3,5,4′- trimethoxystilbene is a potent anti-mitotic drug inhibiting tubulin polymerization. Int J Cancer 2003;107:189-96.
45. Chabert P, Fougerousse A, Brouillard R. Antimitotic properties of resveratrol analog (Z)-3,5,4′-trimethoxystilbene. Biofactors 2006;27:37-46.
46. Mizutani K, Ikeda K, Kawai Y, Yamori Y. Resveratrol stimulates the proliferation and differentiation of osteoblastic MC3T3-E1 cells. Biochem Biophys Res Commun 1998;253:859-63.
47. van der Woude H, Gliszczynska-Swiglo A, Struijs K, Smeets A, Alink GM, Rietjens IM. Biphasic modulation of cell proliferation by quercetin at concentrations physiologically relevant in humans. Cancer Lett 2003;200:41-7.
48. Elattar TM, Virji AS. The inhibitory effect of curcumin, genistein, quercetin and cisplatin on the growth of oral cancer cells in vitro. Anticancer Res 2000;20(3A):1733-8.
49. Brito PM, Mariano A, Almeida LM, Dinis TC. Resveratrol affords protection against peroxynitrite-mediated endothelial cell death: A role for intracellular glutathione. Chem Biol Interact 2006;164:157-66.
50. Cao Z, Li Y. Potent induction of cellular antioxidants and phase 2 enzymes by resveratrol in cardiomyocytes: protection against oxidative and electrophilic injury. Eur J Pharmacol 2004;489:39-48.
51. Surh YJ, Kundu JK, Na HK, Lee JS. Redox-sensitive transcription factors as prime targets for chemoprevention with anti-inflammatory and antioxidative phytochemicals. J Nutr 2005;135(12 Suppl):2993S-3001S.
52. Hsieh TC, Lu X, Wang Z, Wu JM. Induction of quinone reductase NQO1 by resveratrol in human K562 cells involves the antioxidant response element ARE and is accompanied by nuclear translocation of transcription factor Nrf2. Med Chem 2006;2:275-85.
53. Ahmad A, Syed FA, Singh S, Hadi SM. Prooxidant activity of resveratrol in the presence of copper ions: mutagenicity in plasmid DNA. Toxicol Lett 2005;159:1-12.
54. Azmi AS, Bhat SH, Hadi SM. Resveratrol-Cu(II) induced DNA breakage in human peripheral lymphocytes: implications for anticancer properties. FEBS Lett 2005;579:3131-5.
55. Zheng LF, Wei QY, Cai YJ, Fang JG, Zhou B, Yang L, Liu ZL. DNA damage induced by resveratrol and its synthetic analogues in the presence of Cu (II) ions: mechanism and structure-activity relationship. Free Radic Biol Med 2006;41:1807-16.
56. Di Carlo FJ, Fiore JV. On the composition of zymosan. Science 1958;127:756-7.
57. Underhill DM. Macrophage recognition of zymosan particles. J Endotoxin Res 2003;9:176-80.
58. Maeda H, Akaike T. Nitric oxide and oxygen radicals in infection, inflammation, and cancer. Biochemistry (Mosc) 1998;63:854-65.
59. Shvedova AA, Kisin ER, Mercer R, Murray AR, Johnson VJ, Potapovich AI, Tyurina YY, Gorelik O, Arepalli S, Schwegler-Berry D, Hubbs AF, Antonini J, Evans DE, Ku BK, Ramsey D, Maynard A, Kagan VE, Castranova V, Baron P. Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. Am J Physiol Lung Cell Mol Physiol 2005; 289(5): L698-L708.
60. Kim BH, Lee IJ, Lee HY, Hwang BY, Han SB, Kim Y. Distinct inhibitory mechanisms of isoquercitrin gallate and its aglycone on zymosan-induced peroxynitrite production in macrophages. Nitric Oxide; in press (DOI: 10.1016/j.niox.2007.06.002).
61. Speert DP, Wright SD, Silverstein SC, Mah B. Functional characterization of macrophage receptors for in vitro phagocytosis of unopsonized Pseudomonas aeruginosa. J Clin Invest 1988;82:872-9.
62. Brown GD, Taylor PR, Reid DM, Willment JA, Williams DL, Martinez-Pomares L, Wong SY, Gordon S. Dectin-1 is a major beta-glucan receptor on macrophages. J Exp Med 2002;196:407-12.
63. Panzella L, De Lucia M, Amalfitano C, Pezzella A, Evidente A, Napolitano A, d'Ischia M. Acid-promoted reaction of the stilbene antioxidant resveratrol with nitrite ions: mild phenolic oxidation at the 4′-hydroxystiryl sector triggering nitration, dimerization, and aldehydeforming routes. J Org Chem 2006;71:4246-54.
64. De Lucia M, Panzella L, Crescenzi O, Napolitano A, Barone V, d'Ischia M. The catecholic antioxidant piceatannol is an effective nitrosation inhibitor via an unusual double bond nitration. Bioorg Med Chem Lett 2006;16:2238-42.
65. Khan S, Ramwani JJ, O'Brien PJ. Hepatocyte toxicity of mechlorethamine and other alkylating anticancer drugs. Role of lipid peroxidation. Biochem Pharmacol 1992;43:1963-7.